Evidence map›Paper›PMID 24535268›Full record

ArticleMolecular biology reports2014

Inhibition of fluorescent advanced glycation end products (AGEs) of human serum albumin upon incubation with 3-β-hydroxybutyrate.

M Bohlooli, A A Moosavi-Movahedi, F Taghavi, A A Saboury, P Maghami, A Seyedarabi, F Moosavi-Movahedi, F Ahmad, A Shockravi, M Habibi-Rezaei

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Acetoacetate enhancement of glucose mediated DNA glycation.Biochemistry and biophysics reports · 2021
    Article
  6. Article
  7. The role of acetoacetate in Amadori product formation of human serum albumin.Journal of photochemistry and photobiology. B, Biology · 2016
    Article
  8. Protection by beta-Hydroxybutyric acid against insulin glycation, lipid peroxidation and microglial cell apoptosis.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

M BohlooliInstitute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran.
A A Moosavi-Movahedi
F Taghavi
A A Saboury
P Maghami
A Seyedarabi
F Moosavi-Movahedi
F Ahmad
A Shockravi
M Habibi-Rezaei

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advanced glycation end products (AGEs), which are the final products of glycation, have a major role in diabetic complication and neurodegenerative disorders. The 3-β-hydroxybutyrate (3BHB), a ketone body which is produced by the liver, can be detected in increased concentrations in individuals post fasting and prolonged exercises and in diabetic (type I) patients. In this study, the inhibitory effect of 3BHB on AGEs formation by glucose from the human serum albumin (HSA) was studied at physiological conditions after 35 days of incubation, using physical techniques such as circular dichroism and fluorescence spectroscopy, as well as differential scanning calorimetry (DSC). The fluorescence intensity measurements of glycated HSA by glucose (GHSA) in the presence of 3BHB indicate a decrease in AGEs formation. The DSC deconvolution profile results also confirm the protective role of 3BHB on incubated with glucose by preventing the enthalpy reduction of the HSA tail segment, compared with the deconvolution profile seen for incubated with glucose alone. The concentration of 3BHB used in this study is in accordance with the concentration detected in the body of individuals post fasting and prolonged exercises.

Indexed as

3-Hydroxybutyric AcidCalorimetry, Differential ScanningCircular DichroismDiabetes ComplicationsExerciseGlucoseGlycation End Products, AdvancedGlycosylationHumansSerum AlbuminSpectrometry, FluorescenceThermodynamics3-Hydroxybutyric AcidGlucoseGlycation End Products, AdvancedSerum Albumin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.